Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes

Published:2009-12 Issue:25 Volume:54 Page:2358-2362
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Murphy Sabina A.,Cannon Christopher P.,Wiviott Stephen D.,McCabe Carolyn H.,Braunwald Eugene

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Tests for multivariate recurrent events in the presence of a terminal event;Chen;Biostatistics,2004

2. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON–TIMI 38 trial;Murphy;Eur Heart J,2008

3. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

4. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT–TIMI 22;Wiviott;Circulation,2006

5. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)–TIMI 22 trial;Cannon;Am J Cardiol,2002

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Meta-Analysis of Randomized Controlled Trials Comparing the Efficacy and Safety of Hydrophilic Versus Lipophilic Statins in Acute Coronary Syndrome Patients;Cureus;2024-09-02

2. ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction;Journal of the American College of Cardiology;2024-09

3. Impact of Bempedoic Acid on Total Cardiovascular Events;JAMA Cardiology;2024-03-01

4. Lipid clinical trials with special reference to Indian population;Indian Heart Journal;2024-03

5. A comparison between patients with various etiologies of cirrhosis and examination of cardiac risk factors limiting survival to liver transplantation;Clinical Transplantation;2023-12